Audrey Helleboid‐Chapman

458 citations
11 papers · 377 indexed · h-index 9
Topics
Lipid metabolism and disorders (4 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers)Drug Transport and Resistance Mechanisms (3 papers)

In The Last Decade

Audrey Helleboid‐Chapman

10 papers receiving 363 citations

Peers

Audrey Helleboid‐Chapman
Comparison fields: 5 of 45
  • Molecular Biology 168
  • Surgery 140
  • Endocrinology, Diabetes and Metabolism 121
  • Oncology 91
  • Epidemiology 76
Replace Camille Malaval with:
Camille Malaval France
M. Dodson Michael United States
Fayanne E. Thorngate United States
Laurence Berthou France
Michael Charlton United States
Yeo Kyoung Oh South Korea
Marieke Pennings Netherlands
Hidemitsu Sakagami Japan
André van der Zee Netherlands
Keith A. Otto United States
Audrey Helleboid‐Chapman relative to Camille Malaval France Camille Malaval's profile →
Citations per field
00.5×1.5×2.0×
Camille Malaval · 1×
Citations per year

Countries citing papers authored by Audrey Helleboid‐Chapman

Since Specialization
Citations

This map shows the geographic impact of Audrey Helleboid‐Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Helleboid‐Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Helleboid‐Chapman more than expected).

Fields of papers citing papers by Audrey Helleboid‐Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Helleboid‐Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Helleboid‐Chapman. The network helps show where Audrey Helleboid‐Chapman may publish in the future.

Co-authorship network of co-authors of Audrey Helleboid‐Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Helleboid‐Chapman. A scholar is included among the top collaborators of Audrey Helleboid‐Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Helleboid‐Chapman. Audrey Helleboid‐Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 47
2 11
3 36
4 77
5 5
6 13
7 17
8 35
9 90
10 45
11
Phosphorylation-dependent down-regulation of apolipoprotein A5 by insulin
1

About Audrey Helleboid‐Chapman

Audrey Helleboid‐Chapman is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 377 indexed citations. Recurring topics across this work include Lipid metabolism and disorders (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (121 citations), Biochemistry (29 citations) and Oncology (91 citations). Audrey Helleboid‐Chapman has collaborated with scholars based in France, United States and Russia. Frequent co-authors include Bart Staels, Jean‐Charles Fruchart, Jamila Fruchart‐Najib, Heidelinde Jäkel, Maxime Nowak, L Pennacchio, Geneviève Martin, François Pattou, B. Vandewalle and Julie Kerr‐Conte. Their work appears in journals such as Journal of Molecular Biology, Molecular and Cellular Biology and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026